البحرين الآن مكان لتروي فيه قصتك
Dammam, 27/5/2018
Arbah Capital is pleased to announce its investment participation in the over £550 million Regent’s Crescent project located in prime Central London, UK with a shariah compliant mezzanine financing facility of up to £50m.
Regent’s Crescent development is for 76 high end residential units facing Regent’s Park in the heart of London. It is the rebuild of an 1800’s Grade 1 listed building designed by John Nash, who was the architect of Buckingham Palace. The development is expected to be completed in the first half of 2020.
Marylebone, the area in which the development is located, has bucked the trend in Prime Central London and is one of the very few areas in London where prices have shown increases in recent years. The demand remains robust for unique owner occupied, high end residences, which also feature best in class amenities such as a swimming pool, business suite, cinema, access to private gardens, concierge and on-site parking. Pre sales have been encouraging.
Mahmood Al Kooheji, CEO of Arbah Capital, said today that ‘This is a landmark moment in Arbah Capital’s successful progress into becoming an Investment Bank which participates in carefully selected, risk adjusted, investment opportunities internationally. This is just the beginning of an exciting period in our development and shortly we will be bringing further unique investment opportunities for our valued clients.”
Arbah Capital
Established on August 2008, Arbah Capital is licensed by the Capital Market Authority (CMA) in the Kingdom of Saudi Arabia as a closed Saudi joint stock firm, with license number 07083-37, headquartered in Dammam with a paid-up capital of 220 million Saudi Riyals. The firm prides itself on being fully Shari’ah compliant.
The CMA granted Arbah Capital with licenses to operate as Dealing, Managing, Arranging, Custody and Advising. The principal activities of the firm include Asset Management, Real Estate Investment, Private Equity & Corporate Finance, Brokerage, Wealth Management, Custody and Advisory.
End
